Suitable preclinical models such as patient-derived xenografts (PDX) are needed to evaluate drugs specifically targeting kidney cancer. PDX models are known to be the most predictive preclinical model and provide an accurate approach to evaluating an agent’s efficacy prior to entering the clinic. The Crown Bioscience kidney cancer PDX collection consists of several models, including models from both North American and Asian descent. More
PDX offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. Crown Bioscience's HuPrime® PDX models are well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.
MODEL NUMBER | CANCER TYPE | CANCER SUBTYPE | DESCRIPTION | # per page |
---|---|---|---|---|
KI0326 | Kidney Cancer | CCRCC | Clear cell carcinoma of left kidney | CLICK TO VIEW |
KI0551 | Kidney Cancer | TCC | Transitional cell carcinoma | CLICK TO VIEW |
KI10101 | Kidney Cancer | NA | NA for clinical diagnosis info. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
KI10102 | Kidney Cancer | NA | oncocystic neoplasm. Pathol comment: APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
KI10105 | Kidney Cancer | RCC | Renal Carcinoma. Sarcomatoid renal cell carcinoma. | CLICK TO VIEW |
KI10106 | Kidney Cancer | RCC | Renal Cell Carcinoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
KI10115 | Kidney Cancer | NA | cystic nephroma / mixed epithelial and stromal tumor. Pathol comment: NO MALIGNANT CELLS PRESENT IN TISSUE SECTIONS EXAMINED AND CYTOSPIN PREPARATION. TISSUE SECTIONS SHOW A LESION CONSISTENT WITH A CYSTIC NEPHROMA/MIXED EPITHELIAL AND STROMAL TUMOR. | CLICK TO VIEW |
KI11409 | Kidney Cancer | NA | Kidney Carcinoma. Pathol comment: APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
KI1410 | Kidney Cancer | RCC | Metastatic renal clear cell carcinoma to lung. Tumor is forms cribriform or nest structures and has an infiltrative growth pattern. Tumor cells show clear cytoplasm or acidophily cytoplasm with the nuclear atypia. Regional LN: the seventh group LN (1/5), the second group LN (0/5), the fourth group (0/3), the tenth group LN (0/2). | CLICK TO VIEW |
KI16031 | Kidney Cancer | NA | Metastatic clear cell carconoma, C/W RENAL PRIMARY. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. | CLICK TO VIEW |
KI2361 | Kidney Cancer | CCRCC | NA | CLICK TO VIEW |
KI2367 | Kidney Cancer | RCC | Clear cell renal cell carcinoma of right kidney | CLICK TO VIEW |
KI2368 | Kidney Cancer | RCC | Metastatic clear cell renal cell carcinoma of kidney primary (from KI2367) in subcutaneous nodule. IHC results: CD10(+), EMA(+), CK8/18(-), Vimentin(+). | CLICK TO VIEW |
KI2389 | Kidney Cancer | CCRCC | Left kidney: clear cell carcinoma, grade III, with necrosis. | CLICK TO VIEW |
KI2407 | Kidney Cancer | RCC | Renal cell carcinoma, clear cell renal cell carcinoma with focal sarcomatoid component | CLICK TO VIEW |
KI2430 | Kidney Cancer | SCC | N/A | CLICK TO VIEW |
KI2432 | Kidney Cancer | NA | NA | CLICK TO VIEW |
KI2479 | Kidney Cancer | CCRCC | N/A | CLICK TO VIEW |
KI2552 | Kidney Cancer | NA | Lung Met from Renal Cell Carcinoma | CLICK TO VIEW |
KI9309 | Kidney Cancer | NA | NA | CLICK TO VIEW |
KI9310 | Kidney Cancer | NA | NA | CLICK TO VIEW |
KI9316 | Kidney Cancer | RCC | NA | CLICK TO VIEW |
Already Registered? Login
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy